Life Sciences

FDA releases draft guidance for trials of incontinence devices

Device Regulation Alert: Safety, Compliance and Reimbursement News, September 26, 2008

Medical device manufacturers should use a randomized, controlled trial to collect data to demonstrate the safety and effectiveness of urinary incontinence devices, according to FDA draft guidance.

Post a Comment





Please enter your comment below:


Please enter the text below:

    ePharm5 InDepth
  • ePharm5 InDepth

    EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

  • Complete Guide to Lab Safety, 3rd Ed.

    The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...

Most Popular